BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

410 related articles for article (PubMed ID: 9295019)

  • 21. Expression of the Fas ligand in cells of T cell lineage.
    Suda T; Okazaki T; Naito Y; Yokota T; Arai N; Ozaki S; Nakao K; Nagata S
    J Immunol; 1995 Apr; 154(8):3806-13. PubMed ID: 7706720
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CD4+ T cells reactivated with superantigen are both more sensitive to FasL-mediated killing and express a higher level of FasL.
    Wang JK; Zhu B; Ju ST; Tschopp J; Marshak-Rothstein A
    Cell Immunol; 1997 Aug; 179(2):153-64. PubMed ID: 9268499
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Induction of T cell clonal anergy results in resistance, whereas CD28-mediated costimulation primes for susceptibility to Fas- and Bax-mediated programmed cell death.
    Boussiotis VA; Lee BJ; Freeman GJ; Gribben JG; Nadler LM
    J Immunol; 1997 Oct; 159(7):3156-67. PubMed ID: 9317113
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Crosstalk between keratinocytes and T lymphocytes via Fas/Fas ligand interaction: modulation by cytokines.
    Arnold R; Seifert M; Asadullah K; Volk HD
    J Immunol; 1999 Jun; 162(12):7140-7. PubMed ID: 10358159
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Polarization and apoptosis of T cell subsets in idiopathic thrombocytopenic purpura.
    Liu F; Wu C; Yang X; Xiao H; Zhuo X; Cheng Z; Chen Q
    Cell Mol Immunol; 2005 Oct; 2(5):387-92. PubMed ID: 16368066
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Regulation of apoptosis in mature alphabeta+CD4-CD8- antigen-specific suppressor T cell clones.
    Khan Q; Penninger JM; Yang L; Marra LE; Kozieradzki I; Zhang L
    J Immunol; 1999 May; 162(10):5860-7. PubMed ID: 10229821
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A chimeric TCR-beta chain confers increased susceptibility to EAE.
    Petersen TR; Lata R; Spittle E; Bäckström BT
    Mol Immunol; 2007 Jul; 44(14):3473-81. PubMed ID: 17481734
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dendritic cells are resistant to apoptosis through the Fas (CD95/APO-1) pathway.
    Ashany D; Savir A; Bhardwaj N; Elkon KB
    J Immunol; 1999 Nov; 163(10):5303-11. PubMed ID: 10553053
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Activation induces apoptosis in Herpesvirus saimiri-transformed T cells independent of CD95 (Fas, APO-1).
    Bröker BM; Kraft MS; Klauenberg U; Le Deist F; de Villartay JP; Fleckenstein B; Fleischer B; Meinl E
    Eur J Immunol; 1997 Nov; 27(11):2774-80. PubMed ID: 9394798
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Surface T cell Fas receptor/CD95 regulation, in vivo activation, and apoptosis. Activation-induced death can occur without Fas receptor.
    Tucek-Szabo CL; Andjelić S; Lacy E; Elkon KB; Nikolić-Zugić J
    J Immunol; 1996 Jan; 156(1):192-200. PubMed ID: 8598462
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Activation-induced apoptosis and cell surface expression of Fas (CD95) ligand are reciprocally regulated by retinoic acid receptor alpha and gamma and involve nur77 in T cells.
    Tóth R; Szegezdi E; Reichert U; Bernardon JM; Michel S; Ancian P; Kis-Tóth K; Macsári Z; Fésüs L; Szondy Z
    Eur J Immunol; 2001 May; 31(5):1382-91. PubMed ID: 11465095
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of Fas/Fas ligand-mediated apoptosis in murine contact hypersensitivity.
    Xu B; Bulfone-Paus S; Aoyama K; Yu S; Huang P; Morimoto K; Matsushita T; Takeuchi T
    Int Immunopharmacol; 2003 Jul; 3(7):927-38. PubMed ID: 12810350
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differential involvement of a Fas-CPP32-like protease pathway in apoptosis of TCR/CD9-costimulated, naive T cells and TCR-restimulated, activated T cells.
    Park CS; Yashiro Y; Tai XG; Toyo-oka K; Hamaoka T; Yagita H; Okumura K; Neben S; Fujiwara H
    J Immunol; 1998 Jun; 160(12):5790-6. PubMed ID: 9637489
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The role of activation-induced cell death in the differentiation of T-helper-cell subsets.
    Roberts AI; Devadas S; Zhang X; Zhang L; Keegan A; Greeneltch K; Solomon J; Wei L; Das J; Sun E; Liu C; Yuan Z; Zhou JN; Shi Y
    Immunol Res; 2003; 28(3):285-93. PubMed ID: 14713720
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Human melanoma-reactive CD4+ and CD8+ CTL clones resist Fas ligand-induced apoptosis and use Fas/Fas ligand-independent mechanisms for tumor killing.
    Rivoltini L; Radrizzani M; Accornero P; Squarcina P; Chiodoni C; Mazzocchi A; Castelli C; Tarsini P; Viggiano V; Belli F; Colombo MP; Parmiani G
    J Immunol; 1998 Aug; 161(3):1220-30. PubMed ID: 9686582
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antigen-induced cell death of T effector cells in vitro proceeds via the Fas pathway, requires endogenous interferon-gamma and is independent of perforin and granzymes.
    Sobek V; Balkow S; Körner H; Simon MM
    Eur J Immunol; 2002 Sep; 32(9):2490-9. PubMed ID: 12207333
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Down-modulation of CD4+ T helper type 2 and type 0 cells by T helper type 1 cells via Fas/Fas-ligand interaction.
    Hahn S; Stalder T; Wernli M; Bürgin D; Tschopp J; Nagata S; Erb P
    Eur J Immunol; 1995 Sep; 25(9):2679-85. PubMed ID: 7589145
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differential ability of Th1 and Th2 T cells to express Fas ligand and to undergo activation-induced cell death.
    Ramsdell F; Seaman MS; Miller RE; Picha KS; Kennedy MK; Lynch DH
    Int Immunol; 1994 Oct; 6(10):1545-53. PubMed ID: 7530039
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chronic morphine treatment promotes specific Th2 cytokine production by murine T cells in vitro via a Fas/Fas ligand-dependent mechanism.
    Greeneltch KM; Kelly-Welch AE; Shi Y; Keegan AD
    J Immunol; 2005 Oct; 175(8):4999-5005. PubMed ID: 16210602
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Unequal death in T helper cell (Th)1 and Th2 effectors: Th1, but not Th2, effectors undergo rapid Fas/FasL-mediated apoptosis.
    Zhang X; Brunner T; Carter L; Dutton RW; Rogers P; Bradley L; Sato T; Reed JC; Green D; Swain SL
    J Exp Med; 1997 May; 185(10):1837-49. PubMed ID: 9151709
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.